Main focus is on IT, and sure maybe the US dropped the ball somewhere there, but the US is far beyond the leading biotech innovator in the world. This is harder

Main focus is on IT, and sure maybe the US dropped the ball somewhere there, but the US is far beyond the leading biotech innovator in the world. This is harder to oust because of the regulatory standard (maybe a little eroded now, but not much) to sell products in the US market.